Publications

Publications

In addition to using the filters to search, this list may be sorted by clicking on any column header. Titles in orange are linked to the full article text.

Use any combination of the filters and/or perform a keyword(s) search to narrow your results below.

Search Filters
  1. Filter by:
  2. and/or
  3. Clear all filters

Your search returned 1787 results.

Search Results
YearTitleJournalAuthorsApplication(s)
2013The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosomeScienceEngreitz JM, Pandya-Jones A, McDonel P, Shishkin A, Sirokman K, Surka C, Kadri S, Xing J, Goren A, Lander ES, Plath K, and Guttman M
2005The Wolbachia Genome of Brugia malayi: Endosymbiont Evolution within a Human Pathogenic Nematode.PLoS Biology Foster, J., Ganatra, M., Kamal, Ibrahim, Ware, J., Makarova, K., Ivanova, N., Bhattacharyya, A., Kapatral, V., Kumar, S., Posfai, J., Vincze, T., Ingram, J., Moran, L., Lapidus, A., Omelchenko, M., Kyrpides, N., Ghedin, E., Wang, S., Goltsman, E., Joukov, V., Ostrovskaya, O., Tsukerman, K., Mazur, M., Comb, D., Koonin, E.and Slatko, B.
1999The Wolbachia Genome Consortium.Microbiol.and Comparative Genomics Slatko, B.E., O'Neill, S.L., Scott, A.L., Werren, J.L., Blaxter, M.L.and the Wolbachia genome Consortium
2008The Wolbachia endosymbiont of Brugia malayi has an active pyruvate phosphate dikinase.Mol.Biochem.Parasitol.Raverdy, S., Foster, J.M., Roopenian, E.and Carlow, C.K.
2009The Wolbachia endosymbiont of Brugia malayi has an active phosphoglycerate mutase: a candidate target for anti-filarial therapies.Parasitol.Res.Foster, J.M., Raverdy, S., Ganatra, M.B., Colussi, P.A., Taron, C.H.and Carlow, C.K.S.
2008The Wolbachia endosymbiont of Brugia malayi has an active phosphoglycerate mutase: a candidate target for anti-filarial therapies.Parasitol.Res.Foster, J.M., Raverdy, S., Ganatra, M.B., Colussi, P.A., Taron, C.H.and Carlow, C.K.S.
2010The Wolbachia endosymbiont as an anti-filarial nematode target.SymbiosisSlatko, B.E., Taylor, M.J.& Foster, J.M.
2008The way forward, enhanced characterization of therapeutic antibody glycosylation: comparison of three level mass spectrometry-based strategiesJ. Chromatogr. B Analyt. Technol. Biomed. Life Sci.Wagner-Rousset, E., Bednarczyk, A., Bussat, M.C., Colas, O., Corvaïa, N., Schaeffer, C., Van Dorsselaer, A., Beck, A.Glycobiology
2001The VP1-unique region of parvovirus B19: amino acid variability and antigenic stabilityJ. Gen. Virol. Dorsch, S., et al.
2015The use of museum specimens with high-throughput DNA sequen.J Hum Evol. Burrell AS, Disotell TR, Bergey CM.